Hotel-Dieu de France

Beirut BP 165191

0 studies enrolling now · 11 studies all time

What they study most

Afibrinogenemia, Congenital, Behçet's Syndrome, Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC), Congenital Fibrinogen Deficiency, Congenital Heart Disease, Deep Vein Thrombosis, Gastrointestinal Stromal Tumors, Idiopathic Pulmonary Fibrosis, Pancreatic Cancer, Progressive Familial Intrahepatic Cholestasis (PFIC), Small-cell Lung Cancer, Venous Thromboembolism

Studies at this site

• Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND) — Running, not enrolling
• Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
• A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC) — Completed
• Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study — Completed
• Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST) — Stopped early
• Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer — Completed
• A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease — Completed
• Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery — Completed
• Quality of Life in Patients With Congenital Afibrinogenemia — Completed
• Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer — Completed
• A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease — Completed